Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 624,534
  • Shares Outstanding, K 93,214
  • Annual Sales, $ 837,600 K
  • Annual Income, $ -127,300 K
  • EBIT $ -82 M
  • EBITDA $ 36 M
  • 60-Month Beta 1.81
  • Price/Sales 0.77
  • Price/Cash Flow 6.96
  • Price/Book 1.73

Options Overview Details

View History
  • Implied Volatility 371.64% (+95.32%)
  • Historical Volatility 54.06%
  • IV Percentile 98%
  • IV Rank 95.31%
  • IV High 387.33% on 11/18/25
  • IV Low 52.48% on 02/20/25
  • Expected Move (DTE 27) 0.00 (0.00%)
  • Put/Call Vol Ratio 4.00
  • Today's Volume 5
  • Volume Avg (30-Day) 25
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 1,781
  • Open Int (30-Day) 1,897
  • Expected Range 6.55 to 6.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.10
  • Number of Estimates 4
  • High Estimate -0.10
  • Low Estimate -0.11
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.53 +0.31%
on 12/19/25
8.09 -18.99%
on 11/25/25
+0.11 (+1.71%)
since 11/19/25
3-Month
6.10 +7.38%
on 11/07/25
8.59 -23.75%
on 10/16/25
-1.22 (-15.70%)
since 09/19/25
52-Week
3.76 +74.20%
on 08/01/25
15.47 -57.66%
on 02/19/25
-6.62 (-50.27%)
since 12/19/24

Most Recent Stories

More News
Why Myriad Genetics (MYGN) Stock Is Up Today

Why Myriad Genetics (MYGN) Stock Is Up Today

MYGN : 6.55 (-2.24%)
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium

SALT LAKE CITY, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will present new data in eight...

MYGN : 6.55 (-2.24%)
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings?

Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings?

MYGN : 6.55 (-2.24%)
1 Healthcare Stock with Promising Prospects and 2 We Question

1 Healthcare Stock with Promising Prospects and 2 We Question

MYGN : 6.55 (-2.24%)
WST : 272.54 (+1.44%)
ISRG : 572.47 (+1.88%)
Why Myriad Genetics (MYGN) Stock Is Trading Lower Today

Why Myriad Genetics (MYGN) Stock Is Trading Lower Today

MYGN : 6.55 (-2.24%)
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health

BOSTON and SALT LAKE CITY and FULTON, Md., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Clairity,   Myriad Genetics, Inc.  (NASDAQ: MYGN), and  MagView , today announced a joint collaboration in an effort to...

MYGN : 6.55 (-2.24%)
Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know

Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know

UHS : 227.46 (+1.21%)
MYGN : 6.55 (-2.24%)
HCA : 472.98 (+1.38%)
NEOG : 7.20 (-3.61%)
ICUI : 145.15 (-0.70%)
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know

Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know

GH : 99.74 (+2.72%)
AGL : 0.7345 (+5.11%)
EVH : 3.99 (+0.50%)
MYGN : 6.55 (-2.24%)
PODD : 289.62 (-1.11%)
Why Myriad Genetics (MYGN) Stock Is Up Today

Why Myriad Genetics (MYGN) Stock Is Up Today

MYGN : 6.55 (-2.24%)
Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment

Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment

MYGN : 6.55 (-2.24%)

Business Summary

Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made...

See More

Key Turning Points

3rd Resistance Point 6.89
2nd Resistance Point 6.82
1st Resistance Point 6.68
Last Price 6.55
1st Support Level 6.47
2nd Support Level 6.40
3rd Support Level 6.26

See More

52-Week High 15.47
Fibonacci 61.8% 11.00
Fibonacci 50% 9.61
Fibonacci 38.2% 8.23
Last Price 6.55
52-Week Low 3.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar